Publications by authors named "Erkut Borazanci"

Claim this Profile
P
Phase IB trial of high dose ascorbic acid + nab-paclitaxel + cisplatin + gemcitabine in patients with untreated metastatic pancreatic cancer.
Gayle S Jameson, S Danielle LeGrand, Michael S Gordon, Denise J Roe, Betsy C Wertheim, Erkut Borazanci

Redox Biol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-platform comparison of gene expression-based cancer molecular subtyping reveals discrepancies with exome capture methods.
Jaewon J Lee, Mohammed Aldakkak, Ashley B Morrison, Sam Z Thalji, Xianlu L Peng, Erkut H Borazanci

NPJ Precis Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exosomal ALPPL2 and THBS2 as biomarkers for early detection and disease monitoring of pancreatic ductal adenocarcinoma.
Kuntal Halder, Erkut H Borazanci, Gayle S Jameson, Wei Lin, Amber Vrana

Br J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Confirmatory Clinical Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma.
Patricio M Polanco, Tamas Gonda, Erkut Borazanci, Evan S Glazer, Jose G Trevino

Curr Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma.
Aimee L Lucas, Diane M Simeone, Bryson W Katona, Salvatore Paiella, George Zogopoulos, Erkut Borazanci

Gastroenterology· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult pancreatoblastoma: Systematic review of the literature and case report of a young adult patient.
Jacob T Harris, Steve Gurley, Erkut Borazanci

World J Gastrointest Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective analysis of capecitabine maintenance therapy in pancreatic ductal adenocarcinoma.
Jordan Powell, Alexa F Viniotis, Chase Irwin, Gayle S Jameson, Lana Caldwell, Erkut H Borazanci

Ther Adv Med Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skin microbiome differences in pancreatic adenocarcinoma, other cancers, and healthy controls: a pilot study.
Taylor Davis, Katherine T Decker, Dana Hosseini, Gayle Jameson, Erkut Borazanci

Front Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab ± paricalcitol in metastatic pancreatic cancer postmaximal cytoreduction.
Vincent Chung, Angela Alistar, Carlos Becerra, Anup Kasi, Erkut Borazanci

Oncologist· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hand therapy interventions for the prevention of chemotherapy-induced peripheral neuropathy of the hands in patients with pancreatic cancer.
Gayle S Jameson, Cynthia Cooper, Courtney Snyder, Sharon M Buchanan, Terri Strelish, Erkut H Borazanci

Oncologist· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relacorilant plus nab-paclitaxel for the treatment of metastatic pancreatic ductal adenocarcinoma: results from the open-label RELIANT study.
Erkut H Borazanci, Nathan Bahary, Vincent Chung, Timothy K Huyck, Ebenezer A Kio

Oncologist· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2 Trial of Nabpaclitaxel + Gemcitabine ± Olaratumab in Treatment-Naïve Participants with Metastatic Pancreatic Cancer.
Faithlore P Gardner, Zev A Wainberg, Christos Fountzilas, Nathan Bahary, Mark S Womack, Erkut Borazanci

Cancers (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-Human Phase I Study of Minnelide in Patients With Advanced Gastrointestinal Cancers: Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity.
Erkut Borazanci, Ashok Saluja, Jon Gockerman, Mohana Velagapudi, Ronald Korn

Oncologist· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Circulating Panel of circRNA Biomarkers for the Noninvasive and Early Detection of Pancreatic Ductal Adenocarcinoma.
Caiming Xu, Eunsung Jun, Yoshinaga Okugawa, Yuji Toiyama, Erkut Borazanci

Gastroenterology· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Choroidal metastasis of pancreatic adenocarcinoma: case report.
Jahnavi Shriram, Robert Stoltz, Erkut Borazanci

AME Case Rep· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A super-enhancer-regulated RNA-binding protein cascade drives pancreatic cancer.
Corina E Antal, Tae Gyu Oh, Stefan Aigner, En-Ching Luo, Brian A Yee, Erkut Borazanci

Nat Commun· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malignant ascites in pancreatic cancer: Pathophysiology, diagnosis, molecular characterization, and therapeutic strategies.
Margaret Y Han, Erkut H Borazanci

Front Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A rare case of sporadic mismatch repair deficient pancreatic ductal adenocarcinoma that responded to ipilimumab and nivolumab combination treatment: case report.
Margaret Y Han, Erkut Borazanci

J Gastrointest Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tilsotolimod Exploits the TLR9 Pathway to Promote Antigen Presentation and Type 1 IFN Signaling in Solid Tumors: A Multicenter International Phase I/II Trial (ILLUMINATE-101).
Hani Babiker, Erkut Borazanci, Vivek Subbiah, Sanjiv Agarwala, Alain Algazi

Clin Cancer Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study.
Kota Nakamura, Zhongxu Zhu, Souvick Roy, Eunsung Jun, Haiyong Han, Erkut Borazanci

Gastroenterology· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Preclinical and Phase Ib Study of Palbociclib plus Nab-Paclitaxel in Patients with Metastatic Adenocarcinoma of the Pancreas.
Manuel Hidalgo, Rocio Garcia-Carbonero, Kian-Huat Lim, Wells A Messersmith, Ignacio Garrido-Laguna, Erkut Borazanci

Cancer Res Commun· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addendum: The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series.
Kevin Drenner, Gargi D Basu, Laurie J Goodman, Audrey A Ozols, Janine R LoBello, Erkut H Borazanci

Oncotarget· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitomycin C in Homologous Recombination Deficient Metastatic Pancreatic Cancer after Disease Progression on Platinum-Based Chemotherapy and Olaparib.
Gehan Botrus, Denise Roe, Gayle S Jameson, Pedro Luiz Serrano Uson Junior, Ronald Lee Korn, Erkut Hasan Borazanci

Biomedicines· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming Taxane Resistance: Preclinical and Phase 1 Studies of Relacorilant, a Selective Glucocorticoid Receptor Modulator, with Nab-Paclitaxel in Solid Tumors.
Pamela N Munster, Andrew E Greenstein, Gini F Fleming, Erkut Borazanci, Manish R Sharma

Clin Cancer Res· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring.
Yu Shi, Weina Gao, Nikki K Lytle, Peiwu Huang, Xiao Yuan, Erkut Borazanci

Nature· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis